Los Angeles - 
(NewMediaWire) - November 3, 2021 - The
Schall Law Firm, a national shareholder rights litigation firm, announces that
it is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or “the Company”) (NASDAQ: ORGO) for violations of the securities laws.
The investigation
focuses on whether the Company issued false and/or misleading statements and/or
failed to disclose information pertinent to investors. Organogenesis is the
subject of a report published by Value Investors Club on October 12, 2021. The
report alleges that the Company has improperly billed the government for up to
$250 million each year. The report also claims that the Company set pricing for
its wound covering product Affinity “exorbitantly high,” while making the
product extremely lucrative for doctors through rebates. Based on this report,
shares of Organogenesis fell by 14% on the same day.
If
you are a shareholder who suffered a loss, click here to participate.
We
also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East,
Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights
free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The
class in this case has not yet been certified, and until certification occurs,
you are not represented by an attorney. If you choose to take no action, you
can remain an absent class member.
The
Schall Law Firm represents investors around the world and specializes in
securities class action lawsuits and shareholder rights litigation.
This
press release may be considered Attorney Advertising in some jurisdictions
under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
